Affiliation:
1. Department of Cardiology, National Heart Centre, Singapore
Abstract
Access for coronary angiogram and intervention after transcatheter aortic valve implantation (TAVI) is gaining importance with a greater proportion of younger, lower-surgical-risk patients undergoing TAVI. We review current evidence available for coronary access after TAVI and risk factors that hinder such access, and provide a practical guide to optimising coronary access after TAVI.
Publisher
Radcliffe Media Media Ltd
Reference22 articles.
1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695–705. https://doi.org/10.1056/NEJMoa1814052; PMID: 30883058.
2. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706–15. https://doi.org/10.1056/NEJMoa1816885; PMID: 30883053.
3. Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease – implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol 2013;62:1–10. https://doi.org/10.1016/j.jacc.2013.01.096; PMID: 23644089.
4. Danson E, Hansen P, Sen S, et al. Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI. Nat Rev Cardiol 2016;13:276–85. https://doi.org/10.1038/nrcardio.2016.9; PMID: 26864912.
5. Chetcuti S, Kleiman N, Matthews R, et al. TCT-743 percutaneous coronary intervention after self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 2016;68:B300–1. https://doi.org/10.1016/j.jacc.2016.09.156.